MTRAC Innovation Hub for Life Sciences
Forecasted
MTRAC Innovation Hub for Life Sciences supports Michigan researchers developing devices, diagnostics, therapeutics, and healthcare IT through translational research to advance commercialization and human health.
Funder: Michigan Translational Research and Commercialization (MTRAC)
Due Dates (Anticipated): October 2026 (MTRAC mid-stage) | November 2026 (Kickstart) | May 2027 (Kickstart)
Funding Amounts: Kickstart: up to $42,500; MTRAC mid-stage: $100,000–$250,000 in direct costs for one year
Summary: Supports Michigan life sciences researchers advancing commercially promising devices, diagnostics, therapeutics, and healthcare IT toward commercialization.
Key Information: All awarded projects require investigator/institutional cost-share.
Description
The MTRAC Innovation Hub for Life Sciences is a statewide program supporting translational research with high commercial potential and the ultimate goal of improving human health. Co-managed by University of Michigan Innovation Partnerships and the U-M Medical School’s Fast Forward Medical Innovation program, it helps transfer technologies from Michigan research institutions to the private sector. Funding focuses on devices, diagnostics, therapeutics, and healthcare IT.
Kickstart early-stage awards support preliminary studies and development milestones that strengthen a technology’s commercial potential. MTRAC mid-stage awards support proof-of-concept and late-stage translational studies, complemented by regulatory guidance, business plan development, and industry and investment mentorship. The hub seeks to advance commercialization while increasing startups, jobs, industry licenses, and investment in Michigan.
